Is Eli Lilly Stock Outperforming the Nasdaq?

Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading pharmaceutical company that sells Trulicity, Verzenio and Taltz drugs. The company discovers, develops, and markets human pharmaceuticals. With a market cap of $867.6 billion, LLY’s products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and LLY definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the general drug manufacturers industry. As one of the world's leading pharmaceutical companies, LLY has established a robust and diversified product portfolio, featuring a strong array of recently launched, successful medications.